Stock RVU RYVU THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Ryvu Therapeutics S.A.

Equities

RVU

PLSELVT00013

Market Closed - Warsaw S.E.
Other stock markets
 09:25:46 17/05/2024 pm IST 		5-day change 1st Jan Change
55.8 PLN +1.45% Intraday chart for Ryvu Therapeutics S.A. +10.06% -2.96%
13/03 Ryvu Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
06/03 Ryvu Therapeutics to Present Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024 AACR Annual Meeting CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ryvu Therapeutics Announces Executive Changes
CI
Ryvu Therapeutics S.A. Appoints Hendrik Nogai to the Role of Chief Medical Officer
CI
Ryvu Therapeutics S.A. Appoints Hendrik Nogai as Chief Medical Officer, Effective February 1, 2022
CI
Ryvu Therapeutics Appoints Vatnak Vat-Ho as Chief Business Officer
CI
Ryvu Therapeutics Announces Board and Executive Changes
CI
Selvita S.A. Appoints Setareh Shamsili, M.D., Ph.D., as Chief Medical Officer
CI
Selvita S.A. Plans to Separate into Two Companies; Announces Management Changes
CI
Selvita SA Appoints Steffen Heeger as Chief Medical Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RVU Stock
  4. News Ryvu Therapeutics S.A.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW